Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University
Type
Article
Source Title
ACG CASE REPORTS JOURNAL
Year
2022
Volume
9
Issue
7
Page
-
Open Access
Green Published, gold
Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI
10.14309/crj.0000000000000811
Format
PDF
Abstract
We report a case of a 52-year- old woman without previous underlying liver disease, presenting with progressive jaundice and diagnosed with autoimmune hepatitis after 2 doses of an inactivated coronavirus disease 2019 (CoronaVac) vaccine. All serology and histology were compatible with autoimmune hepatitis. Symptoms were improved and liver function tests were normalized after treatment with steroids and azathioprine.
